Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Chinese Patent Office
Harvard Business School
Express Scripts
Deloitte
McKesson
AstraZeneca
McKinsey
Accenture
Fish and Richardson

Generated: October 16, 2017

DrugPatentWatch Database Preview

Sinecatechins - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for sinecatechins and what is the scope of sinecatechins freedom to operate?

Sinecatechins
is the generic ingredient in one branded drug marketed by Medigene Ag and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Sinecatechins has forty-four patent family members in twenty countries and thirteen supplementary protection certificates in eight countries.

There is one drug master file entry for sinecatechins. One supplier is listed for this compound.

Summary for Generic Name: sinecatechins

US Patents:3
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: see list1
Suppliers / Packagers: see list1
Clinical Trials: see list2
Therapeutic Class:Dermatological Agents
Drug Prices:see low prices
DailyMed Link:sinecatechins at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medigene Ag
VEREGEN
sinecatechins
OINTMENT;TOPICAL021902-001Oct 31, 2006RXYesYes► Subscribe► Subscribe ► Subscribe
Medigene Ag
VEREGEN
sinecatechins
OINTMENT;TOPICAL021902-001Oct 31, 2006RXYesYes► Subscribe► SubscribeY ► Subscribe
Medigene Ag
VEREGEN
sinecatechins
OINTMENT;TOPICAL021902-001Oct 31, 2006RXYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: sinecatechins

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medigene Ag
VEREGEN
sinecatechins
OINTMENT;TOPICAL021902-001Oct 31, 2006► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: sinecatechins

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,197,808 Methods for treating hyperplasia► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: sinecatechins

Country Document Number Estimated Expiration
BrazilPI0214256► Subscribe
Russian Federation2302861► Subscribe
Brazil0214256► Subscribe
South Africa200403287► Subscribe
South Korea100956369► Subscribe
Australia2002356673► Subscribe
European Patent Office0842660► Subscribe
Japan3213557► Subscribe
Germany122009000073► Subscribe
Canada2466720► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: SINECATECHINS

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
8Finland► Subscribe
00550Netherlands► SubscribePRODUCT NAME: MENGSEL VAN CATECHOLEN GEISOLEERD UIT EEN EXTRACT VAN GROENE THEE, CAMELLIA SINENSIS, L. O. KUNTZE MET ISOPROPYLMYRISTAAT; NATL. REGISTRATION NO/DATE: RVG 110904 20120920; FIRST REGISTRATION: DE 73486.00.00 20090831
0550Netherlands► SubscribePRODUCT NAME: DROOG EXTRACT VAN GROENE THEE (CAMELLIA SINENSIS (L.) O.KUNZE FOLIUM) WATERIG (24-56:1) WAARVAN 100 MG OVEREENKOMT MET : 55-72 MG VAN (-)- EPIGALLOCATECHINEGALLAAT. EERSTE EXTRACTIEMIDDEL: WATER; NATIONAL REGISTRATION NO/DATE: RVG 110904 20120920; FIRST REGISTRATION: DE 73486.00.00 20090831
2012 00040Denmark► Subscribe
00581Netherlands► SubscribePRODUCT NAME: DROOG EXTRACT VAN GROENE THEE; NAT. REGISTRATION NO/DATE: RVG 110904 20120917; FIRST REGISTRATION: 73486.00.00 20090831
0842660/01Switzerland► SubscribePRODUCT NAME: CAMELLIAE SINENSIS EXTRACTUM SICCUM RAFFINATUM; REGISTRATION NUMBER/DATE: SWISSMEDIC 61895 27.03.2012
90030-4Sweden► SubscribePRODUCT NAME: TORRT EXTRAKT AV CAMELLIA SINENSIS (L.) O. KUNTZE, FOLIUM; NAT. REG. NO/DATE: 47136 20120405; FIRST REG.: DE 73486.00.00 20090831
0 5025-2012Slovakia► SubscribePRODUCT NAME: PURIFIKOVANY SUCHY EXTRAKT ZO ZELENEHO CAJU (CAMELLIA SINENSIS (L.) O. KUNTZE) A IZOPROPYLMYRISTAT; NAT. REGISTRATION NO/DATE: 46/0306/12-S 20120716; FIRST REGISTRATION: DE 73486.00.00 20090831
C/GB15/042United Kingdom► SubscribePRODUCT NAME: DRY EXTRACT FROM CAMELLIA SINENSIS (L.) O.KUNTZE FOLIUM (GREEN TEA LEAVES) CORRESPONDING TO (-)-EPIGALLOCATECHIN GALLATE; REGISTERED: DE 73486.00.00 20090831; UK PL39972/0003 20150324
1448186/01Switzerland► SubscribeFORMER OWNER: MEDIGENE AG, DE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Express Scripts
Cantor Fitzgerald
Chubb
Novartis
Harvard Business School
UBS
Fish and Richardson
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot